Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02880592 · ClinicalTrials.gov registry record · NA
Effect of Fresh Amniotic Membrane in the Treatment of Diabetic Foot Ulcers
A NA study, sponsored by Organogenesis.
- Completed
- Registry status
- NA
- Development phase
- 89
- Enrollment target
NCT02880592: Completed NA study, sponsored by Organogenesis.
NCT02880592 is a NA study that has completed, run by Organogenesis. The registered enrollment target is 89 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02880592, a NA study, has completed, sponsored by Organogenesis.
- COMPLETED
- Registry status
- NA
- Development phase
- 89 participants
- Enrollment target
Study Summary
This is a multi-center, randomized controlled trial designed to evaluate the use of fresh hypothermically stored human amniotic membrane (Affinity; fHSAM) to determine if addition of fHSAM to standard of care (SOC) results in faster healing of Wagner grade 1 and 2 DFUs compared to SOC alone.
Primary Outcome
Time to initial closure of diabetic foot ulcers will be compared between the two groups.
Interventions
- OTHER Standard of care
- OTHER Affinity Allograft
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 89 participants |
| Start Date | 2016-08 |
| Est. Completion | 2019-04-01 |
| Phase | NA |
What the finished NCT02880592 record still lists
NCT02880592 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 89 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 2 interventions - of which Standard of care is the first listed.
NCT02880592 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02880592 about?
NCT02880592 is a clinical study titled "Effect of Fresh Amniotic Membrane in the Treatment of Diabetic Foot Ulcers". This is a multi-center, randomized controlled trial designed to evaluate the use of fresh hypothermically stored human amniotic membrane (Affinity; fHSAM) to determine if addition of fHSAM to standard of care (SOC) results in faster healing of Wagner grade 1 and 2 DFUs compared to SOC alone.
What is the current status of trial NCT02880592?
This trial is currently completed. It is a NA study. The enrollment target is 89 participants. The study started on 2016-08. Estimated completion is 2019-04-01.
What interventions are being tested in trial NCT02880592?
The interventions under investigation include: Standard of care (OTHER), Affinity Allograft (OTHER).
Who is sponsoring clinical trial NCT02880592?
This trial is sponsored by Organogenesis, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02880592's enrollment target sits among peer trials
89 972nd of 2000 higher than 1,029 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03682289 · 89 participants · Phase 2
Ceralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Solid Tumors
- NCT04787939 · 89 participants · NA
Early Feeding After Oral Cavity Reconstruction
- NCT05480449 · 89 participants · Phase 1
Autologous HuCART19 T Cells Manufactured Using the CliniMACS Prodigy Platform for Pediatric B-ALL (huCART19 Prodigy)
- NCT05604131 · 89 participants · Phase 2
Cardiac MRI-guided Deferiprone Therapy for Acute Myocardial Infarction Patients
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia